Compare FEMY & TPCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FEMY | TPCS |
|---|---|---|
| Founded | 2004 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.2M | 34.0M |
| IPO Year | 2021 | 2008 |
| Metric | FEMY | TPCS |
|---|---|---|
| Price | $0.50 | $3.60 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $5.50 | N/A |
| AVG Volume (30 Days) | ★ 442.0K | 59.7K |
| Earning Date | 05-07-2026 | 02-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 8.60 | ★ 64.20 |
| EPS | N/A | ★ N/A |
| Revenue | $1,629,108.00 | ★ $34,031,000.00 |
| Revenue This Year | $59.47 | N/A |
| Revenue Next Year | $150.54 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 51.97 | 7.72 |
| 52 Week Low | $0.31 | $2.08 |
| 52 Week High | $1.63 | $6.25 |
| Indicator | FEMY | TPCS |
|---|---|---|
| Relative Strength Index (RSI) | 41.82 | 39.89 |
| Support Level | $0.48 | $3.23 |
| Resistance Level | $0.58 | $3.85 |
| Average True Range (ATR) | 0.04 | 0.26 |
| MACD | -0.00 | 0.03 |
| Stochastic Oscillator | 12.87 | 41.07 |
Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.
Techprecision Corp manufactures metal fabricated and machined precision components and systems. It offers a full range of services required to transform raw materials into precision finished products. The company's products are used in markets including defense, aerospace, nuclear, medical, and precision industries. All of its operations and customers are located in the United States. The company have two wholly owned subsidiaries that are each reportable segments: Ranor and Stadco. Each reportable segment focuses on the manufacture and assembly of specific components. It derives maximum revenue from Ranor segment.